9f8c17ab-figure-01 (Image 1)
Chemical structure of fludarabine phosphate, the active ingredient in this product.*
Fludarabine Phosphate Injection, Powder, Lyophilized, For Solution
Product Images NDC 45963-609
2 FDA label images from Actavis Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fludarabine Phosphate (NDC 45963-609). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
Fludarabine Phosphate for Injection, USP 50 mg/vial, lyophilized powder for intravenous use, packaged in a single-dose vial. The label states it must be reconstituted prior to use and contains a warning about cytotoxicity. Distributed by Actavis Pharma, Inc., the carton provides storage instructions and notes excipients including mannitol and sodium hydroxide.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
